Outcomes Remain Poor in Blast-Phase CML, Despite Modern TKIs

(MedPage Today) — At the recent American Society of Hematology annual meeting, researchers presented real-world outcomes for patients with blast-phase chronic myeloid leukemia (CML) using data from a multi-institution U.S. cohort.
In this MedPage…